Carl Danzig News Today

Injection-free subgroup results demonstrated that a single intravitreal dose of 4D-150 without any supplemental anti-VEGF injections resulted in stable mean visual acuity that was equal to or higher than in

If youre experiencing any of these problems, you might want to make an appointment with your eye doctor ASAP.

If youre experiencing any of these problems, you might want to make an appointment with your eye doctor ASAP.

If you're experiencing any of these problems, you might want to make an appointment with your eye doctor ASAP.

Eye experts at the 2023 American Society of Retina Specialists meeting stress early intervention, the lifelong commitment to retinal therapeutics, regular checkups, and prevention for optimal eye health.

Last week's FDA approval of avacincaptad pegol marked the second approved treatment for geographic atrophy in 2023. Here, 4 retina specialists discuss the complement inhibitor and what it could represent for patients with GA.

A relationship was found between geographic atrophy growth and worsening vision loss in a post hoc analysis of the phase 3 GATHER1 and GATHER2 pivotal clinical trials investigating avacincaptad pegol, according to Iveric Bio.

In an interview at ARVO 2023, Danzig discusses the post-hoc analysis from the GATHER trials, showing that a reduced rate of vision loss in patients receiving avacincaptad pegol was correlated with reduced GA growth.

- Post-hoc analysis from the GATHER trials, for the first time, signals that reduced rate of vision loss in patients receiving avacincaptad pegol was correlated with reduced geographic atrophy ... | April 23, 2023